Association between statin use and lipid status in quality improvement initiatives: Statin use, a potential surrogate?

Quality in Primary Care

Volumn 20, Issue 6, 2012, Pages 401-407

  Bojadzievski, Trajko ^a   Schaefer, Eric ^a   Hollenbeak, Chris S ^a   Gabbay, Robert A ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Chronic care model; Dyslipidemia; Patient centred medical home; Process measure; Quality improvement; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; BLOOD; CHRONIC DISEASE; DIABETES MELLITUS; DRUG UTILIZATION; HUMAN; MULTICENTER STUDY; PRIMARY HEALTH CARE; RETROSPECTIVE STUDY; STATISTICS; TOTAL QUALITY MANAGEMENT; UNITED STATES;

CHOLESTEROL, LDL; CHRONIC DISEASE; DIABETES MELLITUS; DRUG UTILIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PENNSYLVANIA; PRIMARY HEALTH CARE; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES;

MLCS; MLOWN;

EID: 84875552174     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Jha AK, Perlin JB, Kizer KW and Dudley RA. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. New England Journal of Medicine 2003;348:2218-27. (Pubitemid 36618134)
2. Werner RM and Asch DA. Clinical concerns about clinical performance measurement. Annals of Family Medicine 2007;5:159-63. (Pubitemid 46513486)
3. Werner RM and McNutt R. A new strategy to improve quality: rewarding actions rather than measures. JAMA2009;301:1375-9.
4. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V and Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997;46:1354-9. (Pubitemid 27315286)
5. Waters DD, Brotons C, Chiang CW et al. Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density-lipoprotein cholesterol goals. Circulation 2009; 120: 28-34.
6. Wouter Jukema J, Chiang CW, Ferrnières J et al. Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2. Current Medical Research and Opinion 2589-97.
7. Gabbay RA, Bailit MH, Mauger DT, Wagner EH and Siminerio L. Multipayer patient-centered medical home implementation guided by the chronic care model. Joint Commission Journal on Quality and Patient Safety 2011;37:265-73.
8. Law MR, Wald NJ and Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. British Medical Journal 2003;326: 1423.
9. Baigent C, Blackwell L, Emberson J et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010;376:1670-81
10. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J and Bonomi A. Improving chronic illness care: translating evidence into action. Health Affairs 2001;20:64.
11. Bojadzievski T and Gabbay RA. Patient-centered medical home and diabetes. Diabetes Care 2011;34:1047-53
12. Tsai AC, Morton SC, Mangione CM and Keeler EB. A meta-analysis of interventions to improve care for chronic illnesses. American Journal of Managed Care 2005;11:478-88. (Pubitemid 41208929)
13. Khan L, Mincemoyer S and Gabbay RA. Diabetes registries: where are we and where are we headed? Diabetes Technology and Therapeutics 2009;11:255-62.
14. Davis K, Schoenbaum SC and Audet AM. A 2020 vision of patient-centered primary care. Journal of General Internal Medicine 2005;20:953-7. (Pubitemid 41726683)
15. Efron B. The Jackknife, the Bootstrap and other Resampling Plans. Society for Industrial and Applied Mathematics, Philadelphia, PA; 1982
16. Carpenter J and Bithell J. Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians. Statistics in Medicine 2000;19:1141-64. (Pubitemid 30265928)
17. Standards of medical care in diabetes - 2006. Diabetes Care 2006;29 Suppl 1:S4-12.
18. Ghandehari H, Kamal-Bahl S and Wong ND. Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004. Am Heart J 2008; 156:112-19.
19. Colhoun HM, Betteridge DJ, Durrington PN et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004; 364: 685-96. (Pubitemid 39140624)
20. Bravata DM, Wells CK, Lo AC et al. Processes of care associated with acute stroke outcomes. Archives of Internal Medicine 2010;170:804-10.
21. Fonarow GC, Abraham WT, Albert NM et al. Association between performance measures and clinical outcomes for patients hospitalized with heart failure. JAMA 2007;297:61-70. (Pubitemid 46041727)